Press release
Eisai presents latest findings for lecanemab at Alzheimer’s Association International Conference (AAIC)
July 31, 2024Research and Development Alzheimers, Conference results, Eisai, Neurology
Clarity AD open-label extension (OLE) data show: three years of continuous lecanemab treatment reduced clinical decline by -0.95 vs expected …
PharmaTimes Medical & Scientific Excellence Awards and Nursing Industry Excellence Awards are open for entry
May 13, 2024Business Services MSEA, NIEA, PharmaTimes, awards
Both awards are open for entry until 17 May 2024 and the live awards ceremony will take place on 11 …
PMLiVE’s T40 – open for submissions!
March 28, 2024Business Services PMLive, PMLive T40, Pharmacy, T40
Healthcare agencies can submit their entries free of charge with a deadline of 30 April The 2024 edition of PMLiVE’s …
Austrian state secretary to speak at FlyPharma Europe 2023
September 29, 2023Business Services FlyPharma 2023, Vienna, flypharma
29 September 2023 — London, UK — FlyPharma Europe will welcome Mr Florian Tursky, the Austrian state secretary, to the …
Inizio Engage launches Patient Access Services – an integrated suite of patient support services to enhance access and adherence for specialty therapies
July 18, 2023Business Services Inizio Engage, Patient Access Services, Pharmacy, patient support
Fort Washington, US — Inizio Engage is pleased to announce the launch of Patient Access Services. This custom-built, integrated suite of patient support services …
Virtual Inspections: Embracing the Digital Change
July 12, 2023Manufacturing and Production ACG, Pharmacy, digital, manufacturing, virtual inspections
Virtual inspections must become a part of companies’ repertoires if they aim to maintain quality standards in their organisations. Digital …
Inizio launches strategic engagement offering to transform customer experiences
June 7, 2023Business Services Inizio, Inizio Engage, commercialisation
6 June 2023 – London, UK — Inizio, a global commercialisation partner dedicated to the health and life sciences industry, …
Is the pharmaceutical sector prepared to face a titanium dioxide ban?
May 19, 2023Manufacturing and Production ACG, EMA, EU, Titanium Dioxide
Dr Subhashis Chakraborty, head of Global Product Management, ACG Capsules In the wake of the ban on titanium dioxide (TiO2) …
FlyPharma Europe, Vienna: the early bird deal for FlyPharma Vienna closes on 24 May
May 9, 2023Business Services, Conferences Conference, flypharma
Act now! The early bird deal for FlyPharma Vienna closes on 24 May. Contact Angela Heath, conference director, email angela@samedanltd.com for …
First Patient Dosed in the US in Avacta’s AVA6000 Phase 1 Clinical Study
April 27, 2023Research and Development Avacta
Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, announces that the …
Novartis Cosentyx® gains positive CHMP opinion for hidradenitis suppurativa
April 27, 2023Business Services CHMP, Cosentyx, Dermatology, Novartis
Basel, April 26, 2023 — Novartis announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European …
Aldena Therapeutics and Empa Awarded InnoSuisse Funding to Advance STAR Particles as a Novel Drug Delivery Technology for Dermatology
April 26, 2023Business Services
Boston, Massachusetts, April 26, 2023 – Aldena Therapeutics Inc. (Aldena), a private biotech company pioneering siRNA-based therapies for dermatological indications, …
Epsilogen announces significant expansion of management team with three new senior hires
April 26, 2023Business Services
London, 26 April 2023 – Epsilogen Ltd, a global leader in the development of novel immunoglobulin E (IgE) antibodies to …
Real-world data analysis shows significant improvement in glycaemic management when using a blood glucose monitor connected to the mySugr® app in UK users with type 2 diabetes
April 26, 2023Business Services
Burgess Hill, 26 April 2023 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that real world data shows a …
MiNA Therapeutics Enters Research Collaboration with BioMarin Pharmaceutical to Advance RNAa Platform Research in Rare Genetic Diseases
April 25, 2023Business Services
London, United Kingdom, April 25, 2023 — MiNA Therapeutics, the pioneer of small activating RNA (RNAa) therapeutics, today announced a multi-target …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
